NCT02336347View on ClinicalTrials.gov

A Phase 1 Study Comparing AVP-786 With AVP-923

PHASE1CompletedINTERVENTIONAL
Enrollment

62

Participants

Timeline

Start Date

May 31, 2014

Primary Completion Date

September 30, 2014

Study Completion Date

March 31, 2015

Conditions
Healthy Volunteer
Interventions
DRUG

AVP-786

DRUG

AVP-923

Trial Locations (1)

75247

Covance Dallas Clinical Research Unit, Dallas

Sponsors
All Listed Sponsors
lead

Avanir Pharmaceuticals

INDUSTRY

NCT02336347 - A Phase 1 Study Comparing AVP-786 With AVP-923 | Biotech Hunter | Biotech Hunter